Shizuoka, Japan

Kozo Yao



Average Co-Inventor Count = 8.7

ph-index = 2

Forward Citations = 32(Granted Patents)


Location History:

  • Sunto-gun, JP (1997)
  • Shizuoka, JP (1997 - 2012)

Company Filing History:


Years Active: 1997-2012

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Kozo Yao: Innovator in Pharmaceutical Chemistry

Introduction

Kozo Yao is a distinguished inventor based in Shizuoka, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds with therapeutic applications. With a total of 6 patents to his name, Yao's work has had a meaningful impact on medical science.

Latest Patents

Yao's latest patents include innovative compounds such as tricyclic compounds and quinazoline derivatives. The tricyclic compounds serve as PPAR γ agonists, featuring a complex structure that includes various substituents. These compounds are designed to enhance therapeutic efficacy in treating metabolic disorders. Additionally, his quinazoline derivatives exhibit adenosine uptake inhibitory activity, which is beneficial for protecting the myocardium and preventing renal diseases, including nephritis and diabetic nephropathy.

Career Highlights

Throughout his career, Kozo Yao has worked with notable companies in the pharmaceutical industry, including Kyowa Hakko Kogyo Co., Ltd. and Kyowa Hakko Kirin Co., Limited. His experience in these organizations has allowed him to refine his expertise in drug development and innovation.

Collaborations

Yao has collaborated with esteemed colleagues such as Shigeki Fujiwara and Haruki Takai. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in research.

Conclusion

Kozo Yao's contributions to pharmaceutical chemistry through his innovative patents and collaborations highlight his role as a key figure in the field. His work continues to influence the development of new therapeutic agents that can improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…